Core Insights - Tevogen Bio Holdings Inc. has launched a new initiative called Tevogen Generics to address the increasing focus on pharmaceutical affordability in the U.S. [1] - The initiative aims to expedite domestic manufacturing of unbranded pharmaceuticals and active pharmaceutical ingredients (APIs) to enhance national self-reliance in vital treatments [2] - Tevogen Generics is the third strategic pillar of Tevogen Bio, alongside its existing operations in specialty immunotherapy and artificial intelligence [3][7] Company Leadership - Sadiq Khan, the Chief Commercial Officer, has been appointed as the Interim Head of Tevogen Generics, bringing extensive experience in global commercial operations [2] Strategic Objectives - The primary goal of Tevogen Generics is to make high-quality, essential medicines accessible to all, aligning with national interests in healthcare affordability [7]
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump's Initiative to Encourage Pharmaceutical Manufacturing in United States